NO20054765L - Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav - Google Patents

Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav

Info

Publication number
NO20054765L
NO20054765L NO20054765A NO20054765A NO20054765L NO 20054765 L NO20054765 L NO 20054765L NO 20054765 A NO20054765 A NO 20054765A NO 20054765 A NO20054765 A NO 20054765A NO 20054765 L NO20054765 L NO 20054765L
Authority
NO
Norway
Prior art keywords
effective amount
probiotic organism
preparation
methods
consists essentially
Prior art date
Application number
NO20054765A
Other languages
English (en)
Other versions
NO20054765D0 (no
Inventor
Mitchell Skop
Dilip Chokshi
Original Assignee
Pharmachem Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachem Lab Inc filed Critical Pharmachem Lab Inc
Publication of NO20054765D0 publication Critical patent/NO20054765D0/no
Publication of NO20054765L publication Critical patent/NO20054765L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

2005-12-19 S a m m e n d r a g Det beskrives en myk, tyggbar tilberedning oppnådd uten bruk av sterk varme eller dehydratisering. I én utførelsesform inneholder tilberedningen et virkestoff som i det vesentlige består av en effektiv mengde av minst én probiotisk organisme. I en annen utførelsesform består tilberedningen i det vesentlige av en effektiv mengde av minst én probiotisk organisme og en effektiv mengde av minst ett prebiotisk middel. I en ytterligere utførelsesform består tilberedningen i det vesentlige av en effektiv mengde av minst én probiotisk organisme og et næringsstoff som inngår i en glykoproteinmatriks, eller et enzym, eller begge deler. I nok en annen utførelsesform består tilberedningen i det vesentlige av minst én probiotisk organisme, minst ett prebiotisk middel, og et næringsstoff som inngår i en glykoproteinmatriks, eller et enzym, eller begge deler.
NO20054765A 2003-04-02 2005-10-17 Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav NO20054765L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45978903P 2003-04-02 2003-04-02
PCT/US2004/010164 WO2004089290A2 (en) 2003-04-02 2004-04-01 Novel probiotic compositions and methods of using the same

Publications (2)

Publication Number Publication Date
NO20054765D0 NO20054765D0 (no) 2005-10-17
NO20054765L true NO20054765L (no) 2005-12-19

Family

ID=33159691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054765A NO20054765L (no) 2003-04-02 2005-10-17 Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav

Country Status (6)

Country Link
US (1) US20060263344A1 (no)
EP (1) EP1608314A2 (no)
AU (1) AU2004227998A1 (no)
CA (1) CA2519927A1 (no)
NO (1) NO20054765L (no)
WO (1) WO2004089290A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1478242B1 (en) * 2002-02-21 2014-04-30 Societe Des Produits Nestle S.A. Pet food composition for skin photoprotection
CN101287460B (zh) * 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
CA2661839A1 (en) * 2006-09-05 2008-03-13 Mcneil Nutritionals, Llc Lactase-containing comestibles and related methods
BRPI0811079A2 (pt) 2007-05-03 2014-10-21 Tobias Olofsson Bactérias isoladas de mel fresco ou do trato produtor de mel de abelhas melíferas
GB0709162D0 (en) * 2007-05-11 2007-06-20 Jagotec Ag Dosage foam
EP2187756A1 (en) * 2007-08-24 2010-05-26 Barry Callebaut AG Process and confectionery product produced thereby
US20090196921A1 (en) * 2008-02-06 2009-08-06 The Procter & Gamble Company Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition
CN102292000A (zh) * 2008-12-30 2011-12-21 希尔氏宠物营养品公司 用于提高伴侣动物食品组合物适口性的方法
AU2009335094B2 (en) 2008-12-30 2012-11-15 Hill's Pet Nutrition, Inc. Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
CN102695427B (zh) 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
DE102010009582A1 (de) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
KR101659062B1 (ko) * 2010-02-08 2016-09-21 영남대학교 산학협력단 미국부저병의 원인균에 대한 항균활성을 가지는 페디오코커스 파버러스 ｙｍｌ ００２, 상기 미생물을 함유하는 항균성 미생물제제 및 상기 미생물을 이용한 방제방법
KR101658377B1 (ko) * 2010-02-08 2016-09-21 영남대학교 산학협력단 미국부저병의 원인균에 대한 항균활성을 가지는 락토바실러스 플란타룸 ｙｍｌ ００１, 상기 미생물을 함유하는 항균성 미생물제제 및 상기 미생물을 이용한 방제방법
US20120015075A1 (en) * 2010-07-13 2012-01-19 Hero Nutritionals, LLC Chewable supplement with live microorganisms
CN103687604A (zh) 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
RU2460776C9 (ru) * 2011-04-21 2012-11-10 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus acidophilus, используемый для получения продукции, содержащей лактобактерии
WO2012173587A1 (en) * 2011-06-13 2012-12-20 Hero Nutritionals, LLC Sugar-free chewable supplement
CN106890317A (zh) * 2015-12-17 2017-06-27 吴波峰 一种乳糖酶组合物及其应用
WO2018081441A1 (en) * 2016-10-26 2018-05-03 Nutech Ventures Use of probiotic bacterial strains and cell extracts to inhibit acidosis and liver abscesses in cattle
EA202090769A1 (ru) * 2018-05-04 2020-06-11 Борис Славинович ФАРБЕР Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом
CN109793091A (zh) * 2019-04-03 2019-05-24 江苏惠田农业科技开发有限公司 一种复合莓软糖及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132789A (en) * 1995-12-15 2000-10-17 National Research Council Of Canada Archaeosomes, archaeosomes containing coenzyme Q10, and other types of liposomes containing coenzyme Q10 as adjuvants and as delivery vehicles
US6517886B1 (en) * 1997-06-24 2003-02-11 Biovail Corporation International Positive hydration method of preparing confectionery and the resulting product
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
AU6901501A (en) * 2000-06-13 2001-12-24 Unilever Plc Non-viable lactobacillus containing food product
US6558718B1 (en) * 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation

Also Published As

Publication number Publication date
WO2004089290A3 (en) 2006-09-08
AU2004227998A1 (en) 2004-10-21
WO2004089290A2 (en) 2004-10-21
US20060263344A1 (en) 2006-11-23
EP1608314A2 (en) 2005-12-28
NO20054765D0 (no) 2005-10-17
CA2519927A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
NO20054765L (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
DE602004024924D1 (de) Probiotische tablettenformulierungen
TW200806317A (en) Methods for reducing protein aggregation
EP1411118A4 (en) Cell proliferation inhibitors with anti-glycanic-3 antibody
DK1498039T3 (da) Vitale cellepræparater, som indeholder mælkesyrebakterie som aktivt stof, og mælkesyrebakterieholdige fødevareprodukter
BR0209057A (pt) Composições herbicidas contendo benzoilciclohexanodionas e protetores
BR112017011067A2 (pt) cepas e métodos para a partição de energia em ruminantes
IL211085A0 (en) Perfusion solution
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
EP2275121A3 (en) Protein-based streptococcus pneumoniae vaccines
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
WO2005065456A3 (de) Wirkstoffkombinationen mit insektiziden eigenschaften
BRPI0821373B8 (pt) composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
NO20060955L (no) Farmasoytisk sammensetning som er nyttig til stamcellemobilisering
NO20072890L (no) Behandling av mastitt
BR0314402A (pt) Expansão ex-vivo de populações de células raìzes em culturas celulares mononucleares
DE60107718D1 (de) Konservierung von zellen
FR2883184B1 (fr) Composition de spirulines riche en principes actifs, procede d'obtention et utilisation
EA200701730A1 (ru) Бактериоцины и новые бактериальные штаммы
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2004058353A3 (en) Therapeutic use of selective noradrenaline reuptake inhibitors
NO20055228L (no) Stamceller med okt sensitivitet for SDF-1 og fremgangsmate for fremstilling og anvendelse derav
EA200900247A1 (ru) Подкожные имплантаты, высвобождающие активный компонент в течение длительного времени

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application